An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care
Phase 1
- Conditions
- COVID-19Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- EUCTR2020-001366-11-LT
- Lead Sponsor
- Vilnius University Hospital Santaros Klinikos
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 100000
Inclusion Criteria
consenting adults (age =18) hospitalised with definite COVID-19, not already receiving any of the study drugs
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 500
Exclusion Criteria
known allergy or contra-indications to investigational products
anticipated transfer within 72 hours to a non-study hospital.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method